argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
28 apr 2025 - 07:00
Statutory name
argenx SE
Title
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Date last update: 01 March 2026